Overview

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this was to evaluate valsartan 320mg compared to valsartan 160 mg in terms of blood pressure reduction in a patient population of mild to moderate hypertensives
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Valsartan